125941-87-9
|
|
|
- CAS号:
- 125941-87-9
- 英文名:
- R-(-)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine, hydrochloride
- 英文别名:
- R(+)-SCH-23390;SCH 23390(HCI);SCH 23390 hydrochlor;SCH 23390 HYDROCHLORIDE;SCH 23390 hydrochloride NEW;(+)-SCH23390 Hydrochloride, 98.0+ % (HPLC);R(+)-SCH-23390 HYDROCHLORIDE SELECTIVE D 1 DOPAMINE;SCH23390 HYDROCHLORIDE; SCH-23390 HYDROCHLORIDE; R-(+)-SCH23390 HYDROCHLORIDE;R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine;(5R)-8-Chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol hydrochloride
- 中文名:
- 125941-87-9
- 中文别名:
- SCH 23390 盐酸盐;化合物SCH 23390 HYDROCHLORIDE;(R)-8-氯-3-甲基-5-苯基-2,3,4,5-四氢-1H-苯并[D]氮杂卓-7-醇盐酸盐
- CBNumber:
- CB62131148
- 分子式:
- C17H18ClNOHCl
- 分子量:
- 324.24
- MOL File:
- 125941-87-9.mol
|
|
|
125941-87-9性质、用途与生产工艺
SCH-23390 hydrochloride (R-(+)-SCH-23390, SCH-23390)是一种高效且选择性强的 dopamine D1-like receptor 的拮抗剂，对于D1和D5多巴胺受体亚型的Ki值分别为0.2 nM和0.3 nM。SCH-23390 hydrochloride 是一种有效的 h5-HT2C receptors 的激动剂，Ki值为9.3 nM。SCH-23390 hydrochloride 可直接抑制 G protein-coupled inwardly rectifying potassium (GIRK) channels，IC50值为268 nM。
| Target | Value |
D1 dopamine receptor
(Cell-free assay)
|
0.2 nM(Ki)
|
D5 dopamine receptor
(Cell-free assay)
|
0.3 nM(Ki)
|
h5-HT2C receptor
(Cell-free assay)
|
9.3 nM(Ki)
|
GIRK
(Cell-free assay)
|
268 nM
|
SCH-23390 (1 μM) treatment reverses the inhibitory effects of Isosibiricin on NLRP3 expression and the cleavages of caspase-1 and IL-1β in the LPS-induced BV-2 cells. SCH-23390 could reverse the Isosibiricin-mediated inhibition of the NLRP3/caspase-1 inflammasome pathway.
SCH-23390 can abolish generalized seizures evoked by the chemoconvulsants. SCH-23390 has also been used in studies of other neurological disorders in which the dopamine system has been implicated, such as psychosis and Parkinson's disease. Apart from the study of neurological disorders, SCH-23390 has been extensively used as a tool in the topographical determination of brain D
1
receptors in rodents, nonhuman primates, and humans.
SCH-23390 is a very short-acting compound with an elimination half-life of around 25 min following administration of 0.3 mg/kg i.p. in the rat.
SCH-23390 augments dopamine-induced ductus constriction in CD-1 mouse vessels under newborn O
2
conditions.
125941-87-9
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-19545A | SCH-23390 hydrochloride | | 1 mg | 350元 |
| 2024/04/30 | HY-19545A | 125941-87-9
SCH-23390 hydrochloride | 125941-87-9 | 5mg | 770元 |
125941-87-9, 125941-87-9 相关搜索:
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Heterocycles
- Chiral Reagents
- Aromatics
- Dopamine receptor
- SCH 23390 盐酸盐
- (R)-8-氯-3-甲基-5-苯基-2,3,4,5-四氢-1H-苯并[D]氮杂卓-7-醇盐酸盐
- 化合物SCH 23390 HYDROCHLORIDE
- 125941-87-9
- (R)-8-Chloro-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol hydrochloride
- SCH 23390 hydrochlor
- SCH 23390 hydrochloride NEW
- SCH23390 HYDROCHLORIDE; SCH-23390 HYDROCHLORIDE; R-(+)-SCH23390 HYDROCHLORIDE
- R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
- R(+)-SCH-23390
- (+)-SCH23390 Hydrochloride, 98.0+ % (HPLC)
- SCH 23390(HCI)
- (5R)-8-Chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol hydrochloride
- R(+)-SCH-23390 HYDROCHLORIDE SELECTIVE D 1 DOPAMINE
- SCH 23390 HYDROCHLORIDE
- R(+)-7-CHLORO-8-HYDROXY-3-METHYL-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE